Law360, New York (July 12, 2007, 12:00 AM ET) -- Boehringer Ingelheim Pharma GmbH & Co. KG has filed a patent infringement suit against generic drugmaker Barr Pharmacuticals Inc. to prevent the release of a copycat drug prescribed to lower the risk of strokes.
Ingelheim, Germany-based Boehringer and its affiliates filed the suit Wednesday in a Delaware federal court claiming that Barr infringed a patent for the drug Aggrenox by filing an Abbreviated New Drug Application with the U.S. Food and Drug Administration.
Boehringer was granted FDA approval in 2000 for the drug, which includes 200...
Boehringer Sues Barr Over Generic Stroke Drug
To view the full article, take a free trial now.
